Literature DB >> 7026579

Vimentin: a phosphoprotein under hormonal regulation.

E T Browning, M M Sanders.   

Abstract

Past studies of norepinephrine-stimulated protein phosphorylation in intact C-6 glioma cells had identified a 58,000 molecular weight, 5.7 isoelectric point protein (58K-5.7) as a cyclic AMP-dependent phosphoprotein and had shown that 58K-5.7 was one of the most abundant proteins of the nuclear fraction. Initial experiments of present studies showed that the 58K-5.7 protein remained with the nuclear ghost, or matrix structure, after removal of chromatin. Based on the size, acidity, abundance, nonsolubilization by nonionic detergent and salt, and solubilization by urea, the hypothesis was advanced that the 58K-5.7 protein was the vimentin-type intermediate filament protein. The hypothesis was tested by two types of immunochemical experiments. Antisera against hamster vimentin reacted selectively with only the 58K-5.7 protein in polyacrylamide gels of urea-solubilized cellular residues (i.e., nonionic detergent and 0.6 M salt-insoluble material) as determined by immunoautoradiography. Antisera against the pure 58K-5.7 protein of C-6 cells bound selectively to a fibrous array of cellular material typical of vimentin filaments as determined by indirect immunofluorescence. It is concluded that the 58K-5.7 protein is vimentin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026579      PMCID: PMC2111887          DOI: 10.1083/jcb.90.3.803

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  37 in total

1.  Noradrealine induces morphological alterations in nucleated and enucleated rat C6 glioma cells.

Authors:  J Oey
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

2.  Altered adenosine cyclic 3',5'-monophosphate synthesis and degradation by C-6 astrocytoma cells following prolonged exposure to norepinephrine.

Authors:  E T Browning; C O Brostrom; V E Groppi
Journal:  Mol Pharmacol       Date:  1976-01       Impact factor: 4.436

3.  Effect of denaturation on the susceptibility of proteins to enzymic phosphorylation.

Authors:  D B Bylund; E G Krebs
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

4.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

5.  Adenosine 3',5'-monophosphate in glial tumor cells. Alterations by 5-bromodeoxyuridine.

Authors:  J P Schwartz; N R Morris; B M Breckenridge
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

6.  Norepinephrine-sensitive properties of C-6 astrocytoma cells.

Authors:  E T Browning; J P Schwartz; B M Breckenridge
Journal:  Mol Pharmacol       Date:  1974-01       Impact factor: 4.436

7.  Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. Membrane, soluble, and periplasmic fractions.

Authors:  G F Ames
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Cyclic AMP-mediated induction of ornithine decarboxylase of glioma and neuroblastoma cells.

Authors:  U Bachrach
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

10.  Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase of C-6 glioma cells.

Authors:  J P Schwartz; J V Passonneau
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  13 in total

1.  Follicle-stimulating hormone-dependent phosphorylation of vimentin in cultures of rat Sertoli cells.

Authors:  W A Spruill; A L Steiner; L L Tres; A L Kierszenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

2.  Calcium/calmodulin-dependent phosphorylation of vimentin in rat sertoli cells.

Authors:  W A Spruill; J R Zysk; L L Tres; A L Kierszenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

3.  Basal phosphorylation of cyclic AMP-regulated phosphoproteins in intact S49 mouse lymphoma cells.

Authors:  R A Steinberg; Z Kiss
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

4.  Cyclic AMP-modulated phosphorylation of intermediate filament proteins in cultured avian myogenic cells.

Authors:  D L Gard; E Lazarides
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

5.  Hormonal regulation of protein synthesis, secretion, and phosphorylation in cultured rat Sertoli cells.

Authors:  R M DePhilip; A L Kierszenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Synergistic effects in the alpha 1- and beta 1-adrenergic regulations of intracellular calcium levels in striatal astrocytes.

Authors:  J C Delumeau; P Marin; J Cordier; J Glowinski; J Premont
Journal:  Cell Mol Neurobiol       Date:  1991-04       Impact factor: 5.046

7.  Immunocytochemistry and heterogeneity of rat brain vimentin.

Authors:  V Mares; V Viklický; L M Gerstein; P Dráber; J Ciesielski-Treska
Journal:  Histochemistry       Date:  1988

8.  Delta and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with beta-receptor activated cyclic AMP.

Authors:  P S Eriksson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1992-06       Impact factor: 3.996

9.  Phosphorylation of vimentin in mitotically selected cells. In vitro cyclic AMP-independent kinase and calcium-stimulated phosphatase activities.

Authors:  R M Evans
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

10.  Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase.

Authors:  N J Lamb; A Fernandez; M A Conti; R Adelstein; D B Glass; W J Welch; J R Feramisco
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.